Limited efficacy of targeted treatments in Sjogren's syndrome: why?

被引：0

作者：

Tzioufas, A. G. ^{[1
]}

Goules, A. V. ^{[1
]}

机构：

[1] Athens Sch Med, Dept Pathophysiol, Athens, Greece

来源：

关键词：

Sjogren's syndrome; targeted treatments; efficacy; TNF;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：S27 / S28

页数：2

共 50 条

[41] Sjogren's syndrome
Sood, S
Anthony, R
Pease, CT
CLINICAL OTOLARYNGOLOGY, 2000, 25 (05) : 350 - 357
[42] Sjogren's syndrome
Soliotis, FC
Moutsopoulos, HM
AUTOIMMUNITY, 2004, 37 (04) : 305 - 307
[43] Sjogren's syndrome
Amarasena, Roshan
Bowman, Simon
CLINICAL MEDICINE, 2007, 7 (01) : 53 - 56
[44] Sjogren's syndrome
Manoussakis, MN
Moutsopoulos, HM
OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 1999, 32 (05) : 843 - +
[45] Sjogren's syndrome
Nardelli, E
GIORNALE DI NEUROPSICOFARMACOLOGIA, 1998, 20 (06): : 239 - 240
[46] Sjogren's syndrome
Rehman, HU
YONSEI MEDICAL JOURNAL, 2003, 44 (06) : 947 - 954
[47] Sjogren's syndrome
Andre, Fiona
Boeckle, Barbara C.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2022, 20 (07): : 980 - 1001
[48] Sjogren's syndrome
Delaleu, N
Jonsson, R
Koller, MM
EUROPEAN JOURNAL OF ORAL SCIENCES, 2005, 113 (02) : 101 - 113
[49] Sjogren's syndrome
Fox, RI
Michelson, P
Casiano, CA
Hayashi, J
Stern, M
CLINICS IN DERMATOLOGY, 2000, 18 (05) : 589 - 600
[50] Sjogren's syndrome
Rhodus, NL
QUINTESSENCE INTERNATIONAL, 1999, 30 (10): : 689 - 699